| Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Z Wang, E Klipfell, BJ Bennett, R Koeth, BS Levison, B DuGar, ... nature 472 (7341), 57-63, 2011 | 5912 | 2011 |
| The natural history of nonalcoholic fatty liver disease: a population-based cohort study LA Adams, JF Lymp, JS Sauver, SO Sanderson, KD Lindor, A Feldstein, ... Gastroenterology 129 (1), 113-121, 2005 | 3783 | 2005 |
| The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis MS Ascha, IA Hanouneh, R Lopez, TAR Tamimi, AF Feldstein, NN Zein Hepatology 51 (6), 1972-1978, 2010 | 1565 | 2010 |
| Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis AE Feldstein, A Canbay, P Angulo, M Taniai, LJ Burgart, KD Lindor, ... Gastroenterology 125 (2), 437-443, 2003 | 1345 | 2003 |
| Free fatty acids promote hepatic lipotoxicity by stimulating TNF‐α expression via a lysosomal pathway AE Feldstein, NW Werneburg, A Canbay, ME Guicciardi, SF Bronk, ... Hepatology 40 (1), 185-194, 2004 | 1169 | 2004 |
| NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice AR Mridha, A Wree, AAB Robertson, MM Yeh, CD Johnson, ... Journal of hepatology 66 (5), 1037-1046, 2017 | 983 | 2017 |
| NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice A Wree, A Eguchi, MD McGeough, CA Pena, CD Johnson, A Canbay, ... Hepatology 59 (3), 898-910, 2014 | 961 | 2014 |
| Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study AE Feldstein, A Wieckowska, AR Lopez, YC Liu, NN Zein, AJ McCullough Hepatology 50 (4), 1072-1078, 2009 | 918 | 2009 |
| In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease A Wieckowska, NN Zein, LM Yerian, AR Lopez, AJ McCullough, ... Hepatology 44 (1), 27-33, 2006 | 885 | 2006 |
| The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years AE Feldstein, P Charatcharoenwitthaya, S Treeprasertsuk, JT Benson, ... Gut 58 (11), 1538-1544, 2009 | 865 | 2009 |
| Triggering and resolution of inflammation in NASH S Schuster, D Cabrera, M Arrese, AE Feldstein Nature reviews Gastroenterology & hepatology 15 (6), 349-364, 2018 | 838 | 2018 |
| Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis A Wieckowska, BG Papouchado, ZZ Li, R Lopez, NN Zein, AE Feldstein Official journal of the American College of Gastroenterology| ACG 103 (6 …, 2008 | 753 | 2008 |
| From NAFLD to NASH to cirrhosis—new insights into disease mechanisms A Wree, L Broderick, A Canbay, HM Hoffman, AE Feldstein Nature reviews Gastroenterology & hepatology 10 (11), 627-636, 2013 | 693 | 2013 |
| Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression A Canbay, AE Feldstein, H Higuchi, N Werneburg, A Grambihler, ... Hepatology 38 (5), 1188-1198, 2003 | 594 | 2003 |
| Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future A Wieckowska, AJ McCullough, AE Feldstein Hepatology 46 (2), 582-589, 2007 | 593 | 2007 |
| Innate immunity and inflammation in NAFLD/NASH M Arrese, D Cabrera, AM Kalergis, AE Feldstein Digestive diseases and sciences 61, 1294-1303, 2016 | 526 | 2016 |
| NLRP3 inflammasome activation is required for fibrosis development in NAFLD A Wree, MD McGeough, CA Peña, M Schlattjan, H Li, ME Inzaugarat, ... Journal of molecular medicine 92, 1069-1082, 2014 | 515 | 2014 |
| Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal N Alkhouri, LJ Dixon, AE Feldstein Expert review of gastroenterology & hepatology 3 (4), 445-451, 2009 | 505 | 2009 |
| Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase ZZ Li, M Berk, TM McIntyre, AE Feldstein Journal of Biological Chemistry 284 (9), 5637-5644, 2009 | 501 | 2009 |
| Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo‐controlled trial CO Zein, LM Yerian, P Gogate, R Lopez, JP Kirwan, AE Feldstein, ... Hepatology 54 (5), 1610-1619, 2011 | 478 | 2011 |
Hanne Mette HoffmannMSUΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα msu.edu